<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang G</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>301.e17-301.e28</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8501538</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>39(5)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>We evaluated the prognostic value of 10 putative tumor markers by immunohistochemistry in a large multi-institutional cohort of patients with locally advanced urothelial cancer of the bladder (UCB) with the aim to validate their clinical value and to harmonize protocols for their evaluation.&lt;h4>Materials and methods&lt;/h4>Primary tumor specimens from 576 patients with pathologic (p)T3 UCB were collected from 24 institutions in North America and Europe. Three replicate 0.6-mm core diameter samples were collected for the construction of a tissue microarray (TMA). Immunohistochemistry (IHC) for 10 previously described tumor markers was performed and scored at 3 laboratories independently according to a standardized protocol. Associations between marker positivity and freedom fro</pubmed_abstract><journal>Urologic oncology</journal><pubmed_title>Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project.</pubmed_title><pmcid>PMC8501538</pmcid><funding_grant_id>P30 CA016672</funding_grant_id><funding_grant_id>P50 CA091846</funding_grant_id><funding_grant_id>R01 CA071921</funding_grant_id><pubmed_authors>Dinney CP</pubmed_authors><pubmed_authors>Minner S</pubmed_authors><pubmed_authors>Cote RJ</pubmed_authors><pubmed_authors>Ji L</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Black PC</pubmed_authors><pubmed_authors>Cordon-Cardo C</pubmed_authors><pubmed_authors>Groshen S</pubmed_authors><pubmed_authors>Schmitz-Drager B</pubmed_authors><pubmed_authors>Hawes D</pubmed_authors><pubmed_authors>Sauter G</pubmed_authors><pubmed_authors>Czerniak B</pubmed_authors><pubmed_authors>Waldman F</pubmed_authors><pubmed_authors>Goebell PJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project.</name><description>&lt;h4>Purpose&lt;/h4>We evaluated the prognostic value of 10 putative tumor markers by immunohistochemistry in a large multi-institutional cohort of patients with locally advanced urothelial cancer of the bladder (UCB) with the aim to validate their clinical value and to harmonize protocols for their evaluation.&lt;h4>Materials and methods&lt;/h4>Primary tumor specimens from 576 patients with pathologic (p)T3 UCB were collected from 24 institutions in North America and Europe. Three replicate 0.6-mm core diameter samples were collected for the construction of a tissue microarray (TMA). Immunohistochemistry (IHC) for 10 previously described tumor markers was performed and scored at 3 laboratories independently according to a standardized protocol. Associations between marker positivity and freedom fro</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-05T14:05:32.235Z</modification><creation>2025-04-05T14:05:32.235Z</creation></dates><accession>S-EPMC8501538</accession><cross_references><pubmed>33563539</pubmed><doi>10.1016/j.urolonc.2021.01.021</doi></cross_references></HashMap>